CLINICAL_TRIALS
trial_result
· 2022-07-19
Clinical Trial Update: Study of TER-101 Topical Ointment in Subjects With Atopic Dermatitis [Phase 2]
Summary
Phase 2 trial of TER-101 topical ointment for atopic dermatitis completed; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Teres Bio, Inc. | Conditions: Atopic Dermatitis | Phase 2 | Status: COMPLETED | Results posted: 2022-07-19